FDA NEWS

Gilbert company prime for 'sweet success' - AZCentral.com
A Gilbert company beat several food industry giants in the race to meet federal requirements to sell a new kind of sweetener. Two independent groups of scientists have certified that Wisdom Natural Brands' new SweetLeaf Stevia product is safe for use
Source: www.azcentral.com

Merck halts cholesterol drug study - CNN Money
TRENTON, N.J. (AP) -- Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely 3 weeks after U.S. regulators refused to allow sales of the drug. The drugmaker said Wednesday
Source: money.cnn.com

New safety program to monitor Medicare drug use - San Francisco Gate
Federal health officials will begin monitoring prescription drug usage by millions of Medicare participants in an effort to identify potential safety problems. The Food and Drug Administration has been under increasing pressure to develop a
Source: www.sfgate.com

Wyeth, Nycomed sue Novartis' Sandoz over heartburn drug - Reuters India
REUTERS - Drugmaker Wyeth and its partner Nycomed filed a patent infringement lawsuit against a unit of Novartis AG that sought U.S. Food and Drug Administration approval for a generic version of the heartburn drug Protonix, court papers show
Source: in.reuters.com

Kindler's Struggles Intensify on Pill's Suicide Link (Update4) - Bloomberg
May 22 (Bloomberg) -- Sales of Pfizer Inc.'s quit-smoking pill Chantix are plummeting in the U.S. after regulators tied the drug to suicides, a setback that may depress shares beyond today's 11-year low. U.S. prescriptions for Chantix have dropped by
Source: www.bloomberg.com

Veterans' benefits bill wins approval in Senate - International Herald Tribune
WASHINGTON : Twenty-five Republican senators broke with President George W. Bush and voted Thursday for a major expansion of veterans' benefits as part of a bill to finance another year of the wars in Iraq and Afghanistan. The proposal, adopted by a
Source: www.iht.com

Report on Pfizer's smoking-cessation drug raises safety questions - Forbes
SAN FRANCISCO (Thomson Financial) - A new report by a watchdog group has highlighted serious side effects possibly linked to Pfizer Inc. 's smoking-cessation drug, Chantix, including heart trouble, seizures and diabetes, according to a media report
Source: www.forbes.com

FDA OKs Adolor, GlaxoSmithKline drug Entereg - MSN MoneyCentral
The Food and Drug Administration Tuesday night approved Adolor Corp.'s Entereg drug that's designed to help patients regain gastrointestinal function earlier following bowel resection surgery. The condition the drug was developed to treat, known as
Source: news.moneycentral.msn.com

Labels: FDA